Another man in his late 60s, whose long-term memory was at the third percentile for his age, was on the verge of closing down his business at the start of the study as he could no longer function sufficiently. However, after six months of treatment, he was able to memorize his work schedule and recognize the faces of co-workers, while at the 22-month mark his long-term recall had improved to the 84th percentile. As a result, he did not shut down his business.
Explaining why MEND seems to have succeeded where countless other Alzheimer’s treatments have failed, Bredesen said: “Imagine having a roof with 36 holes in it, and your drug patched one hole very well – the drug may have worked, a single 'hole' may have been fixed, but you still have 35 other leaks, and so the underlying process may not be affected much.”
Previous attempts to reverse the symotoms of Alzheimer's have been largely unsuccessful. Lighthunter/Shutterstock